Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations

In view of the epidemic nature of type 2 diabetes and the substantial rate of failure of current oral antidiabetic drugs the quest for new therapeutics is intensive. The adenosine monophosphate-activated protein kinase (AMPK) is an important regulatory protein for cellular energy balance and is cons...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Gruzman, Arie, Babai, Gali, Sasson, Shlomo
Formato: Artigo
Idioma:Inglês
Publicado: SBDR - Society for Biomedical Diabetes Research 2009
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2712919/
https://ncbi.nlm.nih.gov/pubmed/19557293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1900/RDS.2009.6.13
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares